A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients

A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients

Critically ill patients have considerable oxidative stress. Glutamine and antioxidant supplementation may offer therapeutic benefit, although current data are conflicting. In this blinded 2-by-2 factorial trial, we randomly... read more

Professor Wins Outstanding Investigator Award for Lung Disease Antioxidant Studies

Professor Wins Outstanding Investigator Award for Lung Disease Antioxidant Studies

The National Heart, Lung and Blood Institute (NHLBI) has named the recipient of its inaugural Outstanding Investigator Award: Yvonne Janssen-Heininger, PhD, professor of pathology and laboratory medicine at the Larner College... read more

New Study on Molecular Mechanisms Involved in RILF

New Study on Molecular Mechanisms Involved in RILF

Reversible infantile liver failure (RILF) is a heritable mitochondrial condition that causes severe liver dysfunction in infancy, but those who survive the acute stage typically recover and have no further problems. In work... read more